Adjunctive laser ‐stimulated stem‐cells therapy to primary reperfusion in acute myocardial infarction in humans: Safety and feasibility study

ConclusionLLLT is a safe and feasible adjunctive cell ‐based therapy to PPCI that may benefit ischemic myocardium.

Source: Journal of Interventional Cardiology - December 5, 2018 Category: Cardiology Authors: Gabby Elbaz ‐Greener, Maneesh Sud, Oran Tzuman, Marina Leitman, Zvi Vered, Nissan Ben‐Dov, Uri Oron, Alex Blatt Tags: RANDOMIZED TRIAL Source Type: research